Literature DB >> 25291406

Nanotechnologies for the study of the central nervous system.

A Ajetunmobi1, A Prina-Mello2, Y Volkov1, A Corvin3, D Tropea4.   

Abstract

The impact of central nervous system (CNS) disorders on the human population is significant, contributing almost €800 billion in annual European healthcare costs. These disorders not only have a disabling social impact but also a crippling economic drain on resources. Developing novel therapeutic strategies for these disorders requires a better understanding of events that underlie mechanisms of neural circuit physiology. Studying the relationship between genetic expression, synapse development and circuit physiology in CNS function is a challenging task, involving simultaneous analysis of multiple parameters and the convergence of several disciplines and technological approaches. However, current gold-standard techniques used to study the CNS have limitations that pose unique challenges to furthering our understanding of functional CNS development. The recent advancement in nanotechnologies for biomedical applications has seen the emergence of nanoscience as a key enabling technology for delivering a translational bridge between basic and clinical research. In particular, the development of neuroimaging and electrophysiology tools to identify the aetiology and progression of CNS disorders have led to new insights in our understanding of CNS physiology and the development of novel diagnostic modalities for therapeutic intervention. This review focuses on the latest applications of these nanotechnologies for investigating CNS function and the improved diagnosis of CNS disorders.
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Central nervous system; Electrophysiology; Molecular imaging; Nanomedicine; Nanotechnology; Whole-brain imaging

Mesh:

Substances:

Year:  2014        PMID: 25291406     DOI: 10.1016/j.pneurobio.2014.09.004

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  7 in total

Review 1.  Carbon nanotubes and graphene as emerging candidates in neuroregeneration and neurodrug delivery.

Authors:  Agnes Aruna John; Aruna Priyadharshni Subramanian; Muthu Vignesh Vellayappan; Arunpandian Balaji; Hemanth Mohandas; Saravana Kumar Jaganathan
Journal:  Int J Nanomedicine       Date:  2015-07-02

Review 2.  Vectorized nanodelivery systems for ischemic stroke: a concept and a need.

Authors:  Andrés Da Silva-Candal; Bárbara Argibay; Ramón Iglesias-Rey; Zulema Vargas; Alba Vieites-Prado; Esteban López-Arias; Emilio Rodríguez-Castro; Iria López-Dequidt; Manuel Rodríguez-Yáñez; Yolanda Piñeiro; Tomás Sobrino; Francisco Campos; José Rivas; José Castillo
Journal:  J Nanobiotechnology       Date:  2017-04-11       Impact factor: 10.435

Review 3.  Regenerative Medicine Therapies for Targeting Neuroinflammation After Stroke.

Authors:  Olivera Rajkovic; Geoffrey Potjewyd; Emmanuel Pinteaux
Journal:  Front Neurol       Date:  2018-09-03       Impact factor: 4.003

Review 4.  Advances in Nano Neuroscience: From Nanomaterials to Nanotools.

Authors:  Niccolò Paolo Pampaloni; Michele Giugliano; Denis Scaini; Laura Ballerini; Rossana Rauti
Journal:  Front Neurosci       Date:  2019-01-15       Impact factor: 4.677

5.  Mesoscale brain explorer, a flexible python-based image analysis and visualization tool.

Authors:  Dirk Haupt; Matthieu P Vanni; Federico Bolanos; Catalin Mitelut; Jeffrey M LeDue; Tim H Murphy
Journal:  Neurophotonics       Date:  2017-05-19       Impact factor: 3.593

Review 6.  Biomimetic carbon nanotubes for neurological disease therapeutics as inherent medication.

Authors:  Chenyang Xiang; Yuxuan Zhang; Weisheng Guo; Xing-Jie Liang
Journal:  Acta Pharm Sin B       Date:  2019-11-06       Impact factor: 11.413

Review 7.  Plasmonic Nanoparticles as Optical Sensing Probes for the Detection of Alzheimer's Disease.

Authors:  María Paz Oyarzún; Andreas Tapia-Arellano; Pablo Cabrera; Pedro Jara-Guajardo; Marcelo J Kogan
Journal:  Sensors (Basel)       Date:  2021-03-16       Impact factor: 3.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.